Literature DB >> 29028967

Response to 'The end of the dosage of 6 Thioguanine nucleotides? Not so sure…'.

Akbar K Waljee1,2, Kay Sauder2, Anand Patel3, Sandeep Segar3, Yiwei Zhang4, Ji Zhu4, Ryan W Stidham2, Ulysses Balis5, Peter D R Higgins2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29028967      PMCID： PMC6279054          DOI： 10.1093/ecco-jcc/jjx134

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  7 in total

Review 1.  American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

Authors:  Joseph D Feuerstein; Geoffrey C Nguyen; Sonia S Kupfer; Yngve Falck-Ytter; Siddharth Singh
Journal:  Gastroenterology       Date:  2017-08-03       Impact factor: 22.682

2.  Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.

Authors:  Y González-Lama; F Bermejo; A López-Sanromán; V García-Sánchez; M Esteve; J L Cabriada; A G McNicholl; R Pajares; F Casellas; O Merino; D Carpio; M I Vera; C Muñoz; M Calvo; L M Benito; L Bujanda; F J García-Fernández; E Ricart; D Ginard; M Velasco; J A Carneros; N Manceñido; M Calvo; A Algaba; C Froilan; C Cara; J Maté; L Abreu; J P Gisbert
Journal:  Aliment Pharmacol Ther       Date:  2011-07-03       Impact factor: 8.171

3.  The End of the Dosage of 6-Thioguanine Nucleotides? Not so Sure….

Authors:  Xavier Roblin; Stephane Paul
Journal:  J Crohns Colitis       Date:  2018-01-05       Impact factor: 9.071

4.  External Validation of a Thiopurine Monitoring Algorithm on the SONIC Clinical Trial Dataset.

Authors:  Akbar K Waljee; Kay Sauder; Yiwei Zhang; Ji Zhu; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2017-08-22       Impact factor: 11.382

5.  6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

Authors:  Max Reinshagen; Ekkehard Schütz; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Wolfgang Kruis; Michael Oellerich; Nicolas von Ahsen
Journal:  Clin Chem       Date:  2007-05-10       Impact factor: 8.327

6.  Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Authors:  T Dassopoulos; M C Dubinsky; J L Bentsen; C F Martin; J A Galanko; E G Seidman; R S Sandler; S B Hanauer
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

7.  Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines.

Authors:  Akbar K Waljee; Kay Sauder; Anand Patel; Sandeep Segar; Boang Liu; Yiwei Zhang; Ji Zhu; Ryan W Stidham; Ulysses Balis; Peter D R Higgins
Journal:  J Crohns Colitis       Date:  2017-07-01       Impact factor: 9.071
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.